HOME >> MEDICINE >> NEWS
Mediterranean diet lowers Alzheimer's risk in American cohort

Americans who ate a Mediterranean diet--lots of fruits, vegetables, legumes, cereals, some fish and alcohol, and little dairy and meat--had a reduced risk for Alzheimer's disease as they aged. These findings are published in the April issue of Annals of Neurology, a journal published by John Wiley & Sons. The article is also available online via Wiley Interscience (www.interscience.wiley.com).

Experts theorize that diet may play a role in the development of Alzheimer's disease but epidemiological data on diet and Alzheimer's is conflicting and while individual foods and nutrients have been previously studied, general dietary patterns have not. To address this paucity of data, researchers led by Nikolaos Scarmeas of Columbia University Medical Center, designed a prospective community-based study of 2,258 non-demented people in New York City. The study was funded by the NIH/NIA.

The subjects were part of the Washington Heights-Inwood Columbia Aging project, and for each, the researchers gathered medical and neurological history, did a standardized physical and neurological exam, and conducted an in-person interview to assess health and neuropsychological function. This information was used to diagnose a presence or absence of dementia. Subjects were reassessed approximately every 18 months for an average of 4 years.

The researchers also obtained dietary data from each subject using a semi-quantitative food frequency questionnaire. They determined a Mediterranean Diet score (0-9) based on a previously described method. During the course of the study, 262 members of the study population were diagnosed with Alzheimer's disease.

"Higher adherence to the Mediterranean diet was associated with significantly lower risk of developing Alzheimer's disease," the authors report. For each additional point to Mediterranean diet scores (indicating increased adherence to the diet), Alzheimer's risk dr
'"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
18-Apr-2006


Page: 1 2

Related medicine news :

1. Mediterranean diet halves risk of progressive lung disease
2. Mediterranean diet associated with reduced risk of Alzheimers disease
3. Mediterranean neurosciences in Albania
4. Phenolic compounds may explain Mediterranean diet benefits
5. Abnormal liver tests in a Mediterranean population
6. Mediterranean diet leads to longer life
7. Exercise lowers insulin in breast cancer survivors
8. Folic acid supplementation lowers stroke risk
9. Moderate drinking lowers womens risk of heart attack
10. Biofeedback on abnormal mechanics lowers risk for stress fractures, pain under kneecap
11. Sword swallowers more likely to be injured when distracted or swallowing unusual swords

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mediterranean diet lowers Alzheimer risk American cohort

(Date:6/18/2013)... (PRWEB) June 19, 2013 Looking for a ... monotony of everyday life? , IWALKAWAKE is a guide ... Written by Adam Botha, it focuses on harnessing the powerful ... The book lays out a nine-step guide to finding one’s ... that a person must go through to reach their true ...
(Date:6/18/2013)... Daily Gossip Magazine has always kept its readers entertained ... , The magazine has decided to prepare readers for the ... recipe every week . , According to Daily Gossip ... readers who are looking to get insights into this type ... anabolic food is almost entirely based on healthy, yet tasteful ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 SEATTLE, WA—A ... Farms of Fairview, Oregon, claiming he fell ill with ... berry and pomegranate seed blend. The complaint was ... by Marler Clark, the Seattle-based law firm that has ... , According to the complaint, Brian Brothers consumed “Townsend ...
(Date:6/18/2013)... Warner, NH (PRWEB) June 18, 2013 ... rugged, submersible, battery powered, stand-alone device which can be ... The new stainless steel enclosure of the Temp1000IS comes ... device interfaces with the IFC400 (sold separately) ... docking station for full communications. No more removal of ...
(Date:6/18/2013)... Senior drug regulatory officials from mainland China and Taiwan ... first time in the U.S.—the need for more collaboration between ... in a timely manner. Representatives from the Taiwan and mainland ... and processes in drug review during the Convergence in ... DIA 2013 49th Annual Meeting . , While ...
Breaking Medicine News(10 mins):Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2
(Date:6/18/2013)... , Safinamide significantly improves ... as add-on to levodopa Safinamide is ... in fluctuating PD patients as add-on to levodopa ... ("Newron"), a research and development company focused on ... Zambon S.p.A., a pharmaceutical company strongly committed to ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... VPII Escrow Corp., a newly formed wholly owned Canadian ... approximately $3.2 billion aggregate principal amount of senior unsecured ... 2021 and in 2023, with final tranching determined at ... net proceeds from the offering, together with proceeds from ...
(Date:6/18/2013)... 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share.  In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Cached News: